{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:46Z","timestamp":1762854166361,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.gofs.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T18:54:58Z","timestamp":1568228098000},"page":"747-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Le test HPV dans le d\u00e9pistage et le suivi des patientes pr\u00e9sentant une l\u00e9sion histologique de haut grade du col ut\u00e9rin"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Gonthier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Desportes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Pretet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Aza\u00efs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Mergui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Canlorbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018. R\u00e9seau Francim","key":"10.1016\/j.gofs.2019.09.004_bib0245"},{"key":"10.1016\/j.gofs.2019.09.004_bib0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0255","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.idc.2013.09.001","article-title":"HPV and HPV-associated diseases","volume":"27","author":"Dunne","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.gofs.2019.09.004_bib0260","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16\u00a0or 18\u00a0and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gofs.2019.09.004_bib0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.gofs.2019.09.004_bib0270","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcv.2015.11.020","article-title":"Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none","volume":"76","author":"El-Zein","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0275","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajog.2007.08.055","article-title":"Reducing the burden of glandular carcinomas of the uterine cervix","volume":"197","author":"Herzog","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0280","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"year":"2010","series-title":"Recommandations pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus en France","key":"10.1016\/j.gofs.2019.09.004_bib0285"},{"year":"2016","series-title":"Conduite \u00e0 tenir devant une femme ayant une cytologie cervico-ut\u00e9rine anormale, Collection recommandations et r\u00e9f\u00e9rentiels, version interactive, INCa","key":"10.1016\/j.gofs.2019.09.004_bib0290"},{"year":"2019","series-title":"D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus\u00a0: le test HPV recommand\u00e9 chez les femmes de plus de 30\u00a0ans","key":"10.1016\/j.gofs.2019.09.004_bib0295"},{"year":"2002","series-title":"Conduite \u00e0 tenir devant une patiente ayant un frottis cervico-ut\u00e9rin anormal. Recommandations pour la pratique clinique ANAES 2002","key":"10.1016\/j.gofs.2019.09.004_bib0300"},{"year":"2008","series-title":"Utilisation des test HPV en pratique. Extrait des mises \u00e0 jour en gyn\u00e9cologie m\u00e9dicale","author":"Morcel","key":"10.1016\/j.gofs.2019.09.004_bib0305"},{"issue":"Suppl 1","key":"10.1016\/j.gofs.2019.09.004_bib0310","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jgyn.2007.11.022","article-title":"[Guidelines for the follow-up of women treated for high-grade cervical neoplasia]","volume":"37","author":"Mergui","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"year":"2013","series-title":"Niveau de preuve et gradation des recommandations de bonne pratique","key":"10.1016\/j.gofs.2019.09.004_bib0315"},{"key":"10.1016\/j.gofs.2019.09.004_bib0320","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0001-2015","article-title":"Human Papillomavirus","volume":"4","author":"Burd","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.gofs.2019.09.004_bib0325","first-page":"303","article-title":"Favre Caract\u00e9ristiques de l\u2019infection par les papillomavirus humains dans des frottis cervicaux normaux en France en 2009","volume":"69","author":"Heard","year":"2011","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.gofs.2019.09.004_bib0330","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.09.004_bib0335","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0340","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bjc.2015.11","article-title":"Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter","volume":"112","author":"Giorgi Rossi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gofs.2019.09.004_bib0345","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2018.09.006","article-title":"Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16\/18\u00a0and FAM19A4\/miR124-2\u00a0methylation","volume":"151","author":"Leeman","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0350","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2019.09.004_bib0355","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30\u00a0years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gofs.2019.09.004_bib0360","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gofs.2019.09.004_bib0365","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1701-2163(16)35241-0","article-title":"HPV testing in primary cervical screening: a systematic review and meta-analysis","volume":"34","author":"Murphy","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.gofs.2019.09.004_bib0370","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.09.004_bib0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48\u00a0months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.gofs.2019.09.004_bib0380","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/LGT.0b013e318285437b","article-title":"Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.gofs.2019.09.004_bib0385","doi-asserted-by":"crossref","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"year":"2015","series-title":"Cancer du col de l\u2019ut\u00e9rus. Les R\u00e9f\u00e9rentiels","author":"Beurrier","key":"10.1016\/j.gofs.2019.09.004_bib0390"},{"key":"10.1016\/j.gofs.2019.09.004_bib0395","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ijc.31202","article-title":"Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study","volume":"142","author":"Sand","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gofs.2019.09.004_bib0400","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1471-0528.2011.02929.x","article-title":"Histological recurrence and depth of loop treatment of the cervix in women of reproductive age: incomplete excision versus adverse pregnancy outcome","volume":"118","author":"Ang","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2019.09.004_bib0405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/LGT.0000000000000423","article-title":"Risk factors of post-large loop excision of the transformation zone recurrent high-grade cervical intraepithelial lesion: a prospective cohort study","volume":"23","author":"Demarquet","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.gofs.2019.09.004_bib0410","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2012.06.026","article-title":"Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study","volume":"165","author":"Serati","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0415","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ygyno.2014.09.022","article-title":"Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix","volume":"135","author":"Kong","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0420","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jgyn.2007.12.012","article-title":"Int\u00e9r\u00eat de la recherche du papillomavirus humain (HPV) dans le suivi post-conisation des CIN2-3","volume":"37","author":"Riethmuller","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.gofs.2019.09.004_bib0425","first-page":"CD008054","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2019.09.004_bib0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/LGT.0000000000000349","article-title":"Post\u2013loop electrosurgical excision procedure high-risk Human Papillomavirus testing as a test of cure: the British Columbia experience","volume":"21","author":"Ceballos","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.gofs.2019.09.004_bib0435","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejogrb.2016.12.018","article-title":"HPV-based strategy in follow-up of patients treated for high-grade cervical intra-epithelial neoplasia: 5-year results in a public health surveillance setting","volume":"210","author":"Garutti","year":"2017","journal-title":"Eur J Obstet Gynecol Reproduc Biol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0440","first-page":"965","article-title":"Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia","volume":"100","author":"Elfgren","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0445","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1471-0528.12072","article-title":"Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study","volume":"120","author":"Torn\u00e9","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2019.09.004_bib0450","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.2000.5952","article-title":"Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?","volume":"79","author":"Nagai","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0455","doi-asserted-by":"crossref","first-page":"e13606","DOI":"10.1097\/MD.0000000000013606","article-title":"Persistent HPV-16\u00a0infection leads to recurrence of high-grade cervical intraepithelial neoplasia","volume":"97","author":"Byun","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gofs.2019.09.004_bib0460","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2559.2007.02956.x","article-title":"Natural history and clearance of HPV after treatment of precancerous cervical lesions","volume":"52","author":"Aerssens","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.gofs.2019.09.004_bib0465","unstructured":"NHS Cancer Screening Programmes. Colposcopy and programme management. Guidelines for the NHSCSP 2010."},{"key":"10.1016\/j.gofs.2019.09.004_bib0470","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012\u00a0updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.09.004_bib0475","unstructured":"Surveillance post-th\u00e9rapeutique des l\u00e9sions pr\u00e9canc\u00e9reuses du col de l\u2019ut\u00e9rus. Recommandations et r\u00e9f\u00e9rentiels, note de pr\u00e9 cadrage Inca 2017. www.e-cancer.fr\/content\/download\/203098\/2736746\/file\/Pre-cadrage-Post-therapeutique_AAE_VF.pdf."},{"key":"10.1016\/j.gofs.2019.09.004_bib0480","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","article-title":"Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181\u00a0countries, 2020-99: a modelling study","volume":"20","author":"Simms","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919302740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919302740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:38:10Z","timestamp":1762853890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718919302740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2468718919302740"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2019.09.004","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le test HPV dans le d\u00e9pistage et le suivi des patientes pr\u00e9sentant une l\u00e9sion histologique de haut grade du col ut\u00e9rin","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}